Dymax, a manufacturer of light-curing materials and equipment, exhibited at COMPAMED. Dymax demonstrated its latest developments in medical technology.
Dymax presented its TPO-free adhesives at the show in response to increased market interest in sustainable adhesive solutions and evolving regulatory requirements. For medical technology applications, these products meet biocompatibility requirements in accordance with ISO 10993-5 (cytotoxicity) and other relevant standards.
IBOA-free wearable devices adhesives
Another highlight was the 2000-MW series, designed for the assembly of wearable medical devices. This line of light-curing medical adhesives is formulated without isobornyl acrylate (IBOA), a known skin irritant, and without TPO. These biocompatible adhesives address concerns regarding skin sensitivity and irritation, that are common in the medical wearables market.
Dymax showcased its patented hybrid light-curable adhesive platform which combines the best qualities of anionic and free radical chemistries. HLC™ adhesives utilizing this platform cure in both light and darkness with either UV/Visible light alone or a combination of UV/Visible light and contact/moisture. These adhesives exhibit the physical and performance properties of Dymax light-curable materials, along with the rapid moisture/contact cure characteristics of anionics.
Encompass® adhesives featuring patented See-Cure color change for cure confirmation and Ultra-Red® fluorescing for quality inspection will be highlighted.